Latest Blog Posts Tagged "Research News"
Two New Parkinson's Drugs Approaching Market: FDA Set to Rule on Novel Treatments Funded by MJFF in Early Development
October 17, 2018
The FDA is expected to rule on these two therapies in January 2019. An approval would mark a milestone in MJFF's 'de-risking' strategy.
October 16, 2018
MJFF works to understand the full scope of resources that Parkinson's researchers need and help provide them.
October 09, 2018
MJFF's newest whiteboard video covers the basics of genetics, how genes lead researchers to new understandings and treatments and what genetic research is teaching us about Parkinson's.
October 08, 2018
A recent MJFF-supported study found that nicotine patches do not slow progression in people with early, untreated Parkinson's disease.
October 05, 2018
An MJFF survey evaluated patients' and clinicians' perspectives on and experiences with Rytary in the "real world," outside of clinical trials.
September 24, 2018
MJFF announces 41 new grant awards to better understand, measure, and treat Parkinson's disease, as well as develop new research tools.
September 21, 2018
The designation applies to drugs that have shown an effect on a serious condition or symptom in early clinical data.
September 20, 2018
A study funded by The Michael J. Fox Foundation shows a new treatment improved tremor, slowness and mobility problems in Parkinson's models.
September 17, 2018
MJFF scientists presented and shared ideas at the Biochemical Society's Biennial International LRRK2 Meeting.
September 13, 2018
Deputy CEO, Sohini Chowdhury, talked to Roche for an article discussing PPMI and the importance of sharing data.